From: The cost-effectiveness analysis of newborn screening for inherited metabolic disorders in China using tandem mass spectrometry: a real-world evidence
Item
Early diagnosed
Late diagnosed
Proportion
Number of hospitalizations per year
VLCD
3
4
20%
CPT
80%
OTCD
60%
ARG
MMA
2
50%
IVA
10%
PA
30%
GA